1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow polysaccharide MGN3: new trials by email Literature Review of polysaccharide MGN3 trials Research Report on polysaccharide MGN3
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCV pegylated IFN, Biobran, Ribavirin - Hepatitis C, Chronic | Phase 2 | Completed | Cairo University | 37 | 2012-07-01 | 2016-02-24 |
Hepatitis C, Chronic (1) · Viremia (1)
Cairo University (1)
Abdel Rahaman Zekry, PhD (1) · Dalia Omran, MD (1) · Hany Khattab, MD (1) · Hosny Salama, MD (1) · Mamdouh Ghoneum, MD (1) · Mervat Al Ansary, MD (1) · Nemat Kasem, MD (1) · Rasha Ahmed, MD (1) · Sherif Mousa, MD (1) · Tarneem Darwish, MD (1)